Literature DB >> 11284219

False-positive serological tests in acute malaria.

K Ghosh1, K N Javeri, D Mohanty, B D Parmar, R R Surati, S H Joshi.   

Abstract

A range of serological tests, including rapid plasma reagin (RPR), Widal test, enzyme-linked immunosorbent assay (ELISA) for human immunodeficiency virus (HIV)-1 and -2, direct Coombs' test (DCT), and rheumatoid factor (RF) were performed in a well-characterised cohort of 100 patients with acute malaria (Plasmodium vivax infection: 31 patients; P. falciparum infection: 69 patients). Twenty-five healthy volunteers from a similar area were used as controls. Three patients from the severe P. falciparum group died, the remainder of the patients recovered completely. A large proportion of these patients showed false-positive serological reactions during the acute stage of infection, which became negative on re-testing, four weeks after recovery. In tropical countries such as India, where malaria is endemic, results of serological tests should be interpreted with caution in a patient with pyrexia of unknown origin (PUO).

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284219

Source DB:  PubMed          Journal:  Br J Biomed Sci        ISSN: 0967-4845            Impact factor:   3.829


  11 in total

1.  Performance of a rapid and simple HIV testing algorithm in a multicenter phase III microbicide clinical trial.

Authors:  Tania Crucitti; Doug Taylor; Greet Beelaert; Katrien Fransen; Lut Van Damme
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

2.  Babesiosis as a cause of false-positive HIV serology.

Authors:  Mariola Smotrys; Tara Magge; Samer Alkhuja; Susheer Dilbagh Gandotra
Journal:  BMJ Case Rep       Date:  2018-06-08

3.  False-positive rapid plasma reagin testing in patients with acute Plasmodium vivax malaria: a case control study.

Authors:  Ryan C Maves; Katherine Dean; Nilda Gadea; Eric S Halsey; Paul C F Graf; Andres G Lescano
Journal:  Travel Med Infect Dis       Date:  2013-10-30       Impact factor: 6.211

4.  False-positive results of enzyme immunoassays for human immunodeficiency virus in patients with uncomplicated malaria.

Authors:  Anne F Gasasira; Grant Dorsey; Moses R Kamya; Diane Havlir; Moses Kiggundu; Philip J Rosenthal; Edwin D Charlebois
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 5.  Pathogenesis of anemia in malaria: a concise review.

Authors:  Kanjaksha Ghosh; Kinjalka Ghosh
Journal:  Parasitol Res       Date:  2007-09-16       Impact factor: 2.289

6.  Expansion of HIV and syphilis into the Peruvian Amazon: a survey of four communities of an indigenous Amazonian ethnic group.

Authors:  Ellika C Bartlett; Carol Zavaleta; Connie Fernández; Hugo Razuri; Stalin Vilcarromero; Sten H Vermund; Eduardo Gotuzzo
Journal:  Int J Infect Dis       Date:  2008-08-28       Impact factor: 3.623

7.  Screening for Chronic Infectious Diseases by Serology in Those Presenting with Malaria in London, United Kingdom.

Authors:  Alison Gowland; Emma McGuire; Anna L Goodman
Journal:  Am J Trop Med Hyg       Date:  2021-12-06       Impact factor: 2.345

8.  Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.

Authors:  Annemarie R Kreeftmeijer-Vegter; Perry J van Genderen; Leo G Visser; Wouter F W Bierman; Jan Clerinx; Cees K W van Veldhuizen; Peter J de Vries
Journal:  Malar J       Date:  2012-03-31       Impact factor: 2.979

9.  Longitudinal evaluation of asymptomatic Leishmania infection in HIV-infected individuals in North-West Ethiopia: A pilot study.

Authors:  Johan van Griensven; Saskia van Henten; Bewketu Mengesha; Mekibib Kassa; Emebet Adem; Mengistu Endris Seid; Saïd Abdellati; Wondimu Asefa; Tesfa Simegn; Degnachew Debasu; Tadfe Bogale; Yonas Gedamu; Dorien Van Den Bossche; Wim Adriaensen; Gert Van der Auwera; Lieselotte Cnops; Florian Vogt; Ermias Diro
Journal:  PLoS Negl Trop Dis       Date:  2019-10-08

10.  Prevalence study of yaws in the Democratic Republic of Congo using the lot quality assurance sampling method.

Authors:  Sibylle Gerstl; Gédeon Kiwila; Mehul Dhorda; Sylvaine Lonlas; Mark Myatt; Benoît Kebela Ilunga; Denis Lemasson; Elisabeth Szumilin; Philippe J Guerin; Laurent Ferradini
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.